GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TSH Biopharm Corp Ltd (ROCO:8432) » Definitions » Market Cap

TSH Biopharm (ROCO:8432) Market Cap : NT$2,538.1 Mil (As of May. 20, 2024)


View and export this data going back to 2012. Start your Free Trial

What is TSH Biopharm Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). TSH Biopharm's share price for the quarter that ended in Mar. 2024 was NT$57.5. TSH Biopharm's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 38.4 Mil. Therefore, TSH Biopharm's market cap for the quarter that ended in Mar. 2024 was NT$2,207.9 Mil.

TSH Biopharm's quarterly market cap increased from Sep. 2023 (NT$1,754.8 Mil) to Dec. 2023 (NT$1,931.4 Mil) and increased from Dec. 2023 (NT$1,931.4 Mil) to Mar. 2024 (NT$2,207.9 Mil).

TSH Biopharm's annual market cap increased from Dec. 2021 (NT$1,708.7 Mil) to Dec. 2022 (NT$1,825.8 Mil) and increased from Dec. 2022 (NT$1,825.8 Mil) to Dec. 2023 (NT$1,931.4 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. TSH Biopharm's Enterprise Value for Today is NT$1,593.9 Mil.


TSH Biopharm Market Cap Historical Data

The historical data trend for TSH Biopharm's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TSH Biopharm Market Cap Chart

TSH Biopharm Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,014.24 2,261.64 1,708.71 1,825.82 1,931.42

TSH Biopharm Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,787.43 1,724.07 1,754.79 1,931.42 2,207.89

Competitive Comparison of TSH Biopharm's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, TSH Biopharm's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TSH Biopharm's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TSH Biopharm's Market Cap distribution charts can be found below:

* The bar in red indicates where TSH Biopharm's Market Cap falls into.



TSH Biopharm Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

TSH Biopharm's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=NT$50.3*38.398
=NT$1,931.4

TSH Biopharm's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )=Share Price (Q: Mar. 2024 )*Shares Outstanding (EOP) (Q: Mar. 2024 )
=NT$57.5*38.398
=NT$2,207.9

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TSH Biopharm  (ROCO:8432) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


TSH Biopharm Market Cap Related Terms

Thank you for viewing the detailed overview of TSH Biopharm's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


TSH Biopharm (ROCO:8432) Business Description

Traded in Other Exchanges
N/A
Address
No.3-1, Park Street, 3rd Floor-1, Nangang District, Taipei, TWN, 115
TSH Biopharm Corp Ltd is engaged in the sale of a variety of pharmaceuticals, chemical drugs and biotechnology services. The Company's revenue is earned domestically.

TSH Biopharm (ROCO:8432) Headlines

No Headlines